Your browser doesn't support javascript.
loading
Eculizumab use in patients with pneumococcal-associated hemolytic uremic syndrome and kidney outcomes.
Konopásek, Patrik; Zieg, Jakub.
Affiliation
  • Konopásek P; Department of Pediatric Nephrology, 2nd Faculty of Medicine, University Hospital Motol, Charles University, Prague, Czech Republic. pat.konopasek@gmail.com.
  • Zieg J; Pediatrická Klinika 2. LF UK and FN v Motole, V Úvalu 84, Prague 5, 15006, Czech Republic. pat.konopasek@gmail.com.
Pediatr Nephrol ; 38(12): 4209-4215, 2023 12.
Article in En | MEDLINE | ID: mdl-37306721
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Renal Insufficiency, Chronic / Atypical Hemolytic Uremic Syndrome / Hemolytic-Uremic Syndrome Type of study: Risk_factors_studies Limits: Female / Humans / Male Language: En Journal: Pediatr Nephrol Journal subject: NEFROLOGIA / PEDIATRIA Year: 2023 Document type: Article Affiliation country: República Checa Country of publication: Alemania
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Renal Insufficiency, Chronic / Atypical Hemolytic Uremic Syndrome / Hemolytic-Uremic Syndrome Type of study: Risk_factors_studies Limits: Female / Humans / Male Language: En Journal: Pediatr Nephrol Journal subject: NEFROLOGIA / PEDIATRIA Year: 2023 Document type: Article Affiliation country: República Checa Country of publication: Alemania